提高大麻二醇的生物可用性:开发和评估一种无形大麻二醇粉制剂
Hiroki Aoyama1, Tatsuya Ogawa1, Hitomi Ozawa-Umeta1
1Therabiopharma Inc.
Journal of nutritional science and vitaminology
|August 31, 2025
概括
研究人员开发了一种无形大麻 (CBD) 粉末,以克服其低生物可用性. 这种增强的配方显著增加了CBD的吸收,为改善食品和补充剂的使用铺平了道路.
科学领域:
- 药理学
- 材料科学
背景情况:
- 大麻 (CBD) 具有许多有益的特性,包括抗氧化,抗炎和抗焦虑作用.
- 由于其固有的低口服生物可用性,CBD的临床应用受到阻碍.
- 开发先进的输送系统对于提高CBD的治疗潜力至关重要.
研究的目的:
- 开发一种具有改善生物可用性的无形大麻 (CBD) 粉末配方.
- 在大鼠中评估无形CBD配方的药理学特征.
- 评估不同聚合物对CBD吸收的影响.
主要方法:
- 使用食品级溶剂转移方法制备无形的CBD粉末.
- 在Sprague- Dawley大鼠中进行了药理动力学研究,将无形配方 (F3与PVP,F4与HPMC) 与晶体CBD分离物进行比较.
- 分析了包括Cmax,AUC0- 6h和Tmax在内的关键药理学参数.
主要成果:
- 与晶体CBD相比,无形CBD配方具有显著的生物可用性.
- Cmax增加了3. 9倍 (F3) 和3. 0倍 (F4).
- AUC0- 6h值是5. 3倍 (F3) 和5. 2倍 (F4) 的高,Tmax显著降低.
结论:
- 开发的无形CBD粉末配方显示出卓越的生物可用性.
- 使用PVP和HPMC等聚合物有效增强CBD的吸收.
- 这种配方有望提高CBD在食品和补充剂中的有效性.
相关概念视频
Factors Influencing Drug Absorption: Pharmaceutical Parameters
192
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
192
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
399
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
399
Factors Influencing Drug Absorption: Physicochemical Parameters
429
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
429
Biopharmaceutics and Pharmacokinetics: Overview
2.5K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.5K
Factors Affecting Dissolution: Particle Size and Effective Surface Area
1.0K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.0K
Bioequivalence: Overview
1.2K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.2K


